BACKGROUND Early subclinical atherosclerosis has been mainly researched in carotid arteries. The potential value of
A therosclerotic cardiovascular disease (ASCVD) is the leading cause of mortality and disability in most countries (1) . Approximately 30% of first acute events are fatal, and survivors often experience sequelae and a shortened life expectancy (2, 3) . Primary prevention is thus the best approach to fighting this pandemic disease.
Current algorithms for risk detection, which combine behavioral, clinical, and biochemical markers, are of limited accuracy, and better risk stratification methods are definitely needed (4, 5) .
Used in combination with traditional risk factors, data on subclinical atherosclerosis can provide additional information about the risk of myocardial infarction, stroke, and cardiovascular disease (CVD) mortality (6) (7) (8) . Carotid wall intima-media thickness estimated from ultrasonographic images has been proposed as a surrogate measure of subclinical atherosclerosis (9) . Whereas some prospective studies have shown that intima-media thickness adds predictive capacity to traditional risk prediction models (10), others have not been able to confirm this (7, 8, 11) , and consequently, the 2013 American College of Cardiology (ACC)/American Heart Association (AHA) guideline for CVD risk prediction no longer recommends its measurement (5) . A higher predictive value has been attributed to the presence of carotid plaques, which added a significant net reclassification index of 7.3% in the Framingham Offspring Study cohort (6) and up to 17.7% in subjects with intermediate CVD risk (clinical net reclassification index) in the ARIC (Atherosclerosis Risk In Communities) study (10) . In this study, considering plaques together with intima-media thickness further boosted the reclassification index to 21.7%. Moreover, the association of plaque with events has been confirmed in a meta-analysis of 11 cohort studies including 54,336 subjects (12) .
The potential value of studying the presence of atherosclerotic plaques in other vascular territories, such as the femoral arteries, for further improving the predictive capacity of traditional risk factors is an understudied area. In a post-mortem study in the Netherlands, the femoral artery was the artery most frequently affected by atherosclerosis among 5 peripheral vascular sites, including the common carotid artery (13) . Moreover, recent data from the PESA (Progression of Early Subclinical Atherosclerosis) study have shown a higher prevalence of femoral compared with carotid plaques in an asymptomatic cohort composed of middle-aged men and women (14) . With this background, we hypothesize that early femoral plaques would be more closely associated with traditional risk factors than carotid plaques and, furthermore, that calcification of coronary arteries assessed by computed tomography (CT) would be more associated with femoral than with carotid plaques. The analyses to investigate these hypotheses were conducted on data from the AWHS (Aragon Workers' Health Study), a prospective study designed to identify risk factors for the development of preclinical and clinical atherosclerosis (15) . Laclaustra et al.
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coronary artery calcium score (CACS Diabetes was defined as fasting plasma glucose $126 mg/dl or self-reported treatment with hypoglycemic medication (19) . Current smoking was defined as smoking in the present or having smoked in the last year. Being a former smoker was defined as a subject having smoked at least 50 cigarettes in his lifetime, but not having smoked in the last year. A variable was created counting how many of the following 4 risk factors were present: hypertension, dyslipidemia, diabetes, and current smoking. In addition, the estimation of 10-year ASCVD risk was calculated using the Pooled Cohort Equations for white males, which are on
Subclinical Atherosclerosis in Femoral Arteries the basis of age, total cholesterol, HDL cholesterol, treated or untreated systolic blood pressure, diabetes, and smoking status (5). ASCVD risk was classified as low (<5%), moderate (5% to 7.5%), or high ($7.5%).
STATISTICAL ANALYSES. Data are expressed as mean AE SD or as percentages. Confidence interval (CI) width is 95% unless otherwise stated. Basic group comparisons were performed using the Student t and chi-square tests. Atherosclerosis prevalence and associated 95% CIs for each territory were calculated after adjusting for age and presented as estimations for an age of 50 years. These were calculated by risk factor count. We also calculated a more detailed table of prevalence, stratified not only by risk factor count, but also by specific combinations of risk factors. Estimates were computed from logistic regression models.
In addition, a logistic model including all of the considered risk factors was used to estimate the independent odds ratios of each risk factor adjusted for age (as a linear variable) for the presence of atherosclerosis in each explored territory. Finally, the association of the presence of plaques in the carotid and femoral arteries with positive coronary calcium was also studied with logistic regression models, adjusted for age (as a linear variable) and traditional risk factors, to estimate potential increases of the area under the receiver-operating characteristic (ROC) curve that may result from adding 1 or both peripheral atherosclerotic measurements to the logistic prediction model and to calculate diagnostic odds ratios. As a sensitivity analysis, we repeated this procedure to estimate the area increases above a logistic prediction on the basis of the calculated ASCVD risk. All statistical processing was performed with R statistical software (21), and ROC curves were calculated with the package pROC (22), using DeLong's methods.
RESULTS
The studied sample included 1,423 men with a mean age of 51.0 AE 3.7 years. At least 1 atherosclerotic lesion was present in 1,020 participants (72%). Plaques were detected by ultrasound in 65% of participants (34% in the carotid and 54% in the femoral arteries), and 38%
had positive coronary calcification (CACS 1 to 299 in 34.5% and $300 in 3.7%).
ASSOCIATION OF SUBCLINICAL ATHEROSCLEROSIS
WITH TRADITIONAL RISK FACTORS. Subclinical atherosclerosis was associated with higher prevalence, higher values, and higher number of known cardiovascular risk factors ( Table 1 ). Figure 1 shows estimates of the expected prevalence and location of subclinical atherosclerosis at 50 years of age, depending on the participants' number of risk factors.
Even for participants with no risk factors according to the National Cholesterol Education Program Adult
Treatment Panel III thresholds, the estimated prevalence of atherosclerosis in at least 1 territory surpassed 50% and ranged between 21% and 34% for each individual vessel, whereas the calculated prevalence of atherosclerosis in at least 1 territory reached up to 92% for participants with 3 or more risk factors. Detailed age-strata exploration showed that the prevalence of any atherosclerosis rose among participants with no cardiovascular risk factors across the 5-year age strata from 35% (95% CI: 21% to 52%) in the 40-to 44-year age group to 65% (95% CI: 50% to 77%) in the 55-to 59-year age interval (Online Tables 1 and 2 ).
All traditional risk factors had independent effects on the presence of femoral subclinical atherosclerosis Values are mean AE SD or % (n).
BMI ¼ body mass index; CV ¼ cardiovascular; HbA1c ¼ glycosylated hemoglobin; HDL-C ¼ high-density lipoprotein cholesterol; LDL-C ¼ low-density lipoprotein cholesterol.
( Table 2 ). Current smoking was the independent factor most strongly associated with femoral and carotid plaques, whereas hypertension was the risk factor most strongly associated with the presence of coronary calcium. Only 76 participants had diabetes, and the adjusted association did not show statistical significance for diabetes in the carotid or coronary territories, whereas it was significant for femoral plaques. The accumulation of risk factors had a strong effect on femoral atherosclerosis, which was the territory that drove most of the rise in the association of risk factors with atherosclerotic presence in any territory ( Table 2 ). Figure 2 shows odds ratios of traditional risk factors for subclinical atherosclerosis in each territory. In addition to dependence on modifiable risk factors, the odds of the presence of any atherosclerosis increased by 14% (95% CI: 10% to 18%) per year of age in the studied age range, independently of the existence of other cardiovascular risk factors. This increase was similar for all arteries (carotid: 11%; femoral: 10%; coronary: 13%).
Online Table 3 shows additional data on the ageadjusted prevalence of subclinical atherosclerosis in the different examined locations, according to participants' numbers and types of risk factors. Three or More
Number of Risk Factors
Presence of atherosclerosis in each territory is adjusted for age and stratified by number of cardiovascular risk factors. Values are point estimates (95% confidence intervals). Cardiovascular (CV) risk factors are ordered from highest to lowest prevalence in our sample.
Laclaustra et al.
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The relationship between ASCVD 10-year risk and the extent of subclinical atherosclerosis is shown in Table 4 , Online   Figures 1 and 2 ).
DISCUSSION
The most important findings of the present study are that subclinical atherosclerosis in an otherwise healthy middle-aged male cohort is most likely identifiable in femoral arteries, that femoral atherosclerosis shows the strongest association with cardiovascular risk factors, and that femoral plaques show a higher sensitivity than carotid plaques for the presence of calcified coronary disease (CACS $1 or $300) (Central Illustration). These results validate and further expand on those from the recently reported PESA study ( Figure 5) , which also showed a notably high prevalence of femoral subclinical atherosclerosis in middle-aged subjects, even among those without traditional risk factors (14) . In addition, our work also confirms the inaccuracy of the overlap between risk estimated with clinical data and the actual presence and burden of subclinical atherosclerosis (14, 23, 24) .
EARLY DETECTION OF ATHEROSCLEROSIS TO IMPROVE CARDIOVASCULAR RISK ASSESSMENT.
Early detection and treatment initiation of patients in the process of developing atherosclerosis might be essential for improvement in the prevention of cardiovascular events. Attempts to incorporate carotid intima-media thickness as a marker of risk has yielded mixed data, succeeding in the ARIC study (10), but failing in others (7, 8, 11 ). In the meantime, the Our results match those of the PESA study (14) ,
showing that most subjects (88% in our study) clas- Presence and extent of subclinical atherosclerosis according to the 10-year risk for atherosclerotic cardiovascular disease (ASCVD) calculated using the Pooled Cohort Equations, classified as low (<5%), moderate (5% to 7.5%), or high ($7.5%) risk. Area under the curve values are point estimates (95% confidence intervals). The basic model includes dyslipidemia, current smoking, hypertension, diabetes, and age. The 3 right columns show the statistical significance of the differences between the models: the first of these columns evaluates the area of the model that adds femoral plaques using the model that adds carotid plaques as a reference; the second column uses the base model as a reference; and the third column uses the full model as a reference.
CACS ¼ coronary artery calcium score; CV ¼ cardiovascular; OR ¼ odds ratio; Ref. ¼ reference.
susceptibilities to cardiovascular disease. However, the disproportionately high association of current smoking with femoral subclinical atherosclerosis might indicate that detection of femoral plaques is a less specific marker in smokers than in nonsmokers.
Tobacco consumption is highly associated with lower extremity peripheral arterial disease (27) , increasing the risk of this disease by 2-to 6-fold and the risk of 
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